Bios Capital Management, Lp Top Holdings and 13F Report (2026)

About Bios Capital Management, Lp

Investment Activity

  • Bios Capital Management, Lp has $34.17 billion in total holdings as of September 30, 2026.
  • Bios Capital Management, Lp owns shares of 6 different stocks, but just 3 companies or ETFs make up 80% of its holdings.
  • About 0.04% of the portfolio was sold this quarter.
  • This quarter, Bios Capital Management, Lp has purchased 6 new stocks and bought additional shares in 0 stocks.
  • Bios Capital Management, Lp sold shares of 1 stock and completely divested from 0 stocks this quarter.

Largest Holdings

OPUS GENETICS INC
$17,827,796,000
ACTUATE THERAPEUTICS INC
$7,838,997,000
Cognition Therapeutics
$5,760,000,000
REIN THERAPEUTICS INC
$2,397,830,000
Lantern Pharma
$238,254,000

Largest Sales this Quarter

Lantern Pharma
13,502 shares (about $13.64M)

Sector Allocation Over Time

Map of 500 Largest Holdings ofBios Capital Management, Lp

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
OPUS GENETICS INC
$17,827,796,0000.0%3,683,42952.2%COM
ACTUATE THERAPEUTICS INC
$7,838,997,0000.0%10,049,99622.9%COM
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
$5,760,000,0000.0%6,000,00016.9%Healthcare
REIN THERAPEUTICS INC
$2,397,830,0000.0%2,982,3757.0%COM NEW
Lantern Pharma Inc. stock logo
LTRN
Lantern Pharma
$238,254,000$13,637,023 ▼-5.4%235,8950.7%Healthcare
IN8BIO INC
$107,673,0000.0%80,9570.3%COM NEW

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data